Abstract CT252: A dose escalation phase I study of concurrent GDC-0084 with radiation therapy for patients with solid tumor brain metastases or leptomeningeal metastases harboring PI3K pathway mutations.
Publishied in AACR - August 2020.-
https://cancerres.aacrjournals.org/content/80/16_Supplement/CT252
Regards.
Phase I study of concurrent GDC-0084 with radiation therapy
Add to My Watchlist
What is My Watchlist?